Seeking Alpha

BrainStorm's (BCLI.OB -2%) NurOwn adult stem cell therapy for treating Lou Gehrig's Disease...

BrainStorm's (BCLI.OB -2%) NurOwn adult stem cell therapy for treating Lou Gehrig's Disease brought about "improvement in many of the patients involved" in a small Phase I/II trial. Stem cells derived from patients' own bone marrow were treated with NurOwn before being transplanted back into the patients.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)